Baxter International (NYSE: BAX) — Company Overview, News & Financial Data
Baxter International specializes in healthcare products for critical therapies, focusing on kidney health and immune disorders globally.
Baxter International
Baxter International is a global medical technology company that develops, manufactures, and markets a broad portfolio of healthcare products, medical devices, and pharmaceutical therapies. Its operations encompass clinical nutrition, intravenous solutions, infusion systems, surgical sealants, patient monitoring equipment, smart hospital beds, and diagnostic tools used in hospitals, primary care facilities, and home care environments. Following the divestiture of its kidney care business, the company focuses on advancing patient care, streamlining clinical workflows, and supporting critical care delivery across hospital networks and healthcare providers globally.
Snapshot
Operations
Products and/or services of Baxter International
- Medical Products & Therapies: Manages intravenous solutions, administration sets, infusion pumps, vascular access devices, and parenteral nutrition products used across hospital, clinical, and alternate site care settings to deliver essential fluids and medications.
- Healthcare Systems & Technologies: Manufactures smart hospital beds, patient room technology, clinical workflow communication systems, and patient monitoring systems designed to optimize care team efficiency and improve patient outcomes in acute care environments.
- Advanced Surgery: Produces surgical sealants, total hemostatic agents, tissue adhesives, and biosurgery products utilized by surgical teams during operations to control bleeding, prevent tissue adhesion, and improve surgical recovery.
- Pharmaceuticals: Supplies ready-to-use injectable medications, inhaled anesthesia agents, generic injectable pharmaceuticals, and specialized pharmacy compounding services for hospital critical care, surgical suites, and specialized clinical departments globally.
- Front Line Care: Offers vital signs monitoring equipment, physical assessment diagnostic tools, cardiology screening devices, and respiratory care products used by primary care physicians, emergency care providers, and health system outpatient centers.
- Clinical Nutrition: Delivers specialized parenteral nutrition formulations, lipid emulsions, amino acid infusions, and automated compounding technologies designed to provide essential nutrient support to critical care and chronically ill patients.
Baxter International executive team
- Mr. Joel T. GradeExecutive VP & CFO
- Mr. Andrew P. HiderCEO, President, Interim Group President of Medical Products & Therapies and Director
- Ms. Anita A. ZielinskiSenior VP, Chief Accounting Officer & Controller
- Ms. Tobi Karchmer M.D., M.S.Senior VP and Chief Medical & Scientific Officer
- Mr. Charles Rusty PatelSenior VP & Chief Information Officer
- Mr. Kevin MoranVice President & Head of Investor Relations
- Mr. David S. RosenbloomExecutive VP & General Counsel
- Ms. Stacey EisenSVP, Chief Communications Officer & Corporate Marketing and President of Baxter Foundation
- Ms. Jeanne K. Mason Ph.D.Executive VP & Chief Human Resources Officer
- Mr. James W. BorziExecutive VP & Chief Supply Chain Officer